Literature DB >> 18836707

Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing--a multilevel analysis of rosuvastatin prescription in south Sweden.

Henrik Ohlsson1, Basile Chaix, Juan Merlo.   

Abstract

PURPOSE: To investigate the role that both patient and outpatient factors related to health care practice (HCP) play in physicians' early adoption of rosuvastatin.
MATERIALS AND METHODS: Generalized estimation equations (GEEs) and alternating logistic regression (ALR) with pair-wise odds ratios (PWORs) were used to measure similarities in rosuvastatin prescription within HCPs for all individuals with statin prescriptions in Skåne region, Sweden.
RESULTS: After 12 months, 53% of the HCPs had adopted the new statin. Rosuvastatin prescriptions co-occurred within certain HCPs 3.56 times more often than one would have expected based on a random distribution. Private HCPs had four times higher probability of prescribing rosuvastatin than public HCPs.
CONCLUSION: Contextual characteristics of the HCP seem to be relevant for understanding physicians' motivation to adopt rosuvastatin. Moreover, our study reveals inequity in health care as the socioeconomic status of the patients appears to influence the prescribing behavior of the physicians irrespective of medical reasons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836707     DOI: 10.1007/s00228-008-0569-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  34 in total

1.  Diffusion of new drugs in Danish general practice.

Authors:  F H Steffensen; H T Sørensen; F Olesen
Journal:  Fam Pract       Date:  1999-08       Impact factor: 2.267

2.  A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs.

Authors:  Ann Jacoby; Monica Smith; Martin Eccles
Journal:  Br J Gen Pract       Date:  2003-02       Impact factor: 5.386

3.  Social processes in physicians' adoption of a new drug.

Authors:  J COLEMAN; H MENZEL; E KATZ
Journal:  J Chronic Dis       Date:  1959-01

4.  A pharmaco-epidemiological analysis of factors associated with antimicrobial consumption level in turkey broiler flocks.

Authors:  Claire Chauvin; Isabelle Bouvarel; Pierre-Alexandre Beloeil; Jean-Pierre Orand; Didier Guillemot; Pascal Sanders
Journal:  Vet Res       Date:  2005 Mar-Apr       Impact factor: 3.683

5.  General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study.

Authors:  Torben Dybdahl; Morten Andersen; Jakob Kragstrup; Ivar Sønbø Kristiansen; Jens Søndergaard
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

6.  Clusters of marijuana use in the United States.

Authors:  G V Bobashev; J C Anthony
Journal:  Am J Epidemiol       Date:  1998-12-15       Impact factor: 4.897

7.  [Evaluation of the proper use of medicines in primary care. How can this be improved?].

Authors:  B González López-Valcárcel; V Ortún Rubio; J Martín Oliva; A Cabeza Mora; A López Cabañas; J A Díaz Berenguer; F Alamo Santana
Journal:  Aten Primaria       Date:  2002-10-31       Impact factor: 1.137

8.  Medical practice variations revisited.

Authors:  H L Smits
Journal:  Health Aff (Millwood)       Date:  1986       Impact factor: 6.301

9.  Assessment of the magnitude of geographical variations and socioeconomic contextual effects on ischaemic heart disease mortality: a multilevel survival analysis of a large Swedish cohort.

Authors:  Basile Chaix; Maria Rosvall; Juan Merlo
Journal:  J Epidemiol Community Health       Date:  2007-04       Impact factor: 3.710

10.  Is general practitioner decision making associated with patient socio-economic status?

Authors:  A Scott; A Shiell; M King
Journal:  Soc Sci Med       Date:  1996-01       Impact factor: 4.634

View more
  12 in total

1.  Practice variation in a longitudinal perspective: a multilevel analysis of the prescription of simvastatin in general practices between 2003 and 2009.

Authors:  Henrik Ohlsson; Marcia Vervloet; Liset van Dijk
Journal:  Eur J Clin Pharmacol       Date:  2011-06-23       Impact factor: 2.953

2.  Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database.

Authors:  Per Hjerpe; Henrik Ohlsson; Ulf Lindblad; Kristina Bengtsson Boström; Juan Merlo
Journal:  Eur J Clin Pharmacol       Date:  2010-12-29       Impact factor: 2.953

3.  Association of Neighborhood Disadvantage and Anticoagulation for Patients with Atrial Fibrillation in the Veterans Health Administration: the REACH-AF Study.

Authors:  Annie McDermott; Nadejda Kim; Leslie R M Hausmann; Jared W Magnani; Chester B Good; Terrence M A Litam; Maria K Mor; Toluwa D Omole; Walid F Gellad; Michael J Fine; Utibe R Essien
Journal:  J Gen Intern Med       Date:  2022-09-23       Impact factor: 6.473

4.  Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database.

Authors:  Per Hjerpe; Juan Merlo; Henrik Ohlsson; Kristina Bengtsson Boström; Ulf Lindblad
Journal:  BMC Med Inform Decis Mak       Date:  2010-04-23       Impact factor: 2.796

5.  Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication.

Authors:  Helle Wallach-Kildemoes; Ebba Holme Hansen
Journal:  Eur J Clin Pharmacol       Date:  2015-07-31       Impact factor: 2.953

6.  Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study.

Authors:  Härkönen Mirva; Timonen Johanna; Tervola Jussi; Katri Aaltonen
Journal:  Eur J Clin Pharmacol       Date:  2015-07-31       Impact factor: 2.953

7.  Selective prescribing of simvastatin and atorvastatin by patient characteristics at treatment initiation over a 7-year period in Finland.

Authors:  Heli Halava; Arja Helin-Salmivaara; Jouni Junnila; Risto Huupponen
Journal:  Eur J Clin Pharmacol       Date:  2009-05-27       Impact factor: 2.953

8.  Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption.

Authors:  Molly L Tanenbaum; Rebecca N Adams; Monica S Lanning; Sarah J Hanes; Bianca I Agustin; Diana Naranjo; Korey K Hood
Journal:  J Diabetes Sci Technol       Date:  2018-07-11

Review 9.  Factors affecting the uptake of new medicines: a systematic literature review.

Authors:  Ágnes Lublóy
Journal:  BMC Health Serv Res       Date:  2014-10-20       Impact factor: 2.655

10.  Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users: a cohort study in the French national health insurance database.

Authors:  Anke Neumann; Géric Maura; Alain Weill; Philippe Ricordeau; François Alla; Hubert Allemand
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-12-02       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.